Good Results with Individually Adapted Long-Term Immunosuppression Following Alemtuzumab Versus ATG Induction Therapy in Combined Kidney-Pancreas Transplantation: A Single-Center Report.

ABSTRACT:

SUBMITTER: Bosmuller C 

PROVIDER: S-EPMC6363467 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature